Loading organizations...
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Jan 1, 2023 | Oxford Ionics | $37.0M Series A | Braavos Investment Advisers, Will Goodlad | 2xN, Amadeus Capital Partners, Earlybird Venture Capital, Outrun Ventures, Plug & Play Ventures, Hermann Hauser, Lansdowne Partners, Prosus Ventures, Torch Partners |
| Nov 7, 2022 | Osler Diagnostics | $85.0M Series C | — | Lansdowne Partners, M&G Investments, Oxford Science Enterprises |
| Jun 1, 2022 | CHARM Therapeutics | $50.0M Series A | OrbiMed, Nihal Sinha | Andreessen Horowitz, Bowery Capital, Creandum, EQT Partners, Flex Capital, F-Prime Capital Partners, General Catalyst, Hyperplane Venture Capital, Khosla Ventures, Kinnevik, Matthew McAviney, Silence, Roger Ehrenberg, Shervin Pishevar, Susanna Campbell, Axial, Grep VC |
| Feb 1, 2021 | SpyBiotech | $33.0M Series A | Andre Crawford-Brunt, Jane Smit | 24Haymarket, 33N Ventures, Accel, Bright Pixel Capital, Tom Hulme, GV, Oxford Science Enterprises, UK Government |